1.Case of myofibril myopathy.
Lili CHEN ; Fangming LIU ; Jiangtao FU
Chinese Acupuncture & Moxibustion 2015;35(12):1304-1304
2.Early efficacy of alendronate in treatment of osteoporotic vertebral compression fractures vertebroplasty postoperative residual pain
He FANG ; Fangming HE ; Yinghua FU
Chinese Journal of Biochemical Pharmaceutics 2015;35(10):35-37
Objective To study the efficacy of alendronate in treatment of postoperative residual pain with osteoporotic vertebral compression fractures(OVCF) of vertebroplasty.Methods 62 patients with OVCF from September 2013 to October 2014 were divided into observation group and control group, each had 31 cases.All patients were given calcium carbonate D3 tablets 1 day after surgery, observation group were given alendronate on this basis.The degree of pain score between two groups pre-and post-treatment two weeks, one month, two months were observed and compared.Pain improvement in two groups were observed, and activity ability score, painkiller use and bone mineral density between two groups pre-and post-treatment were compared.Results The pain scores in observation group a month postoperative was (0.8 ±0.4) points and (0.4 ±0.2) points after two months, were significantly lower than those in control group[(1.6 ±0.7) points, (1.1 ±0.8) points, P<0.05].The excellent rate of pain improvement in observation group(83.87%) was significantly higher than that in control group (58.06%, P <0.05) .After treatment, activity ability score in observation group was (1.13 ±0.53) points and painkiller usage was (0.44 ±0.07) times per day, all significantly lower than those in control group [(1.79 ±0.89) points, (0.89 ±0.12) times per day, P<0.05].BMD level in observation group was (5.78 ±1.02)%, higher than that in control group[(3.21 ±0.79)%, P<0.05].Conclusion Alendronate in treatment of osteoporotic vertebral compression fractures vertebroplasty postoperative residual pain has good early outcome and low adverse reactions, and security is relatively high.
3.The effect of vaslartan and fluvastatin on the connective tissue growth factor expression in experimental diabetic cardiomyopathy
Yongjian WANG ; Guosheng FU ; Fangming CHEN ; Hui WANG
Chinese Journal of Internal Medicine 2009;48(8):660-665
the two drugs than using one alone.
4.Effect of coping styles and personality in etiology of Graves' disease
Shaolian WANG ; Dailin WEI ; Fangming FU ; Yan ZHOU ; Haijun WANG ; Mingqi QIAO ; Huiyun ZHANG
Chinese Journal of Behavioral Medicine and Brain Science 2011;20(6):522-524
Objective To explore the role of coping styles and personalities in the etiology of Graves' disease (GD). Methods All participants (581 patients and 800 normal controls) completed the general information questionnaires,trait coping style questionnaires(TCSQ) and eysenck personality questionnaires revised,short scale for Chinese(EPQ-RSC). Basic characteristics of all subjects were documented, and logistic regression analysis was used to analyze the role of coping styles and personality in etiology of GD. Results The negative coping style(OR = 1.068,P=0.000) ,concealing character(OR = 1. 121, P=0.000) and internal and external personality (OR = 1.089, P = 0.005) neurotic personality (OR > 1.000, P< 0.05) were risk factors of GD( OR = 1. 162, P = 0.000) ,positive coping style was protective factor of GD( OR < 1.000, P<0.05). Conclusion Positive coping style and specific personality adjustment can prevent effectively onset of GD.